| |
| | Seraphim Life Sciences |
 | | Seraphim provides life sciences companies and investors with a new approach to consulting and due diligence. |
 | | Prior to co-founding Seraphim, he was the EVP of Iatros Bio/Pharma Inc. Previously, he was a FDA/CBER reviewer, and an attorney in the FDA/Life Sciences practices of two leading international law firms, where he counseled leading companies and venture firms in the development, licensing and regulation of biologics, pharmaceuticals, and medical devices. |
 | | She has held senior management positions at SmithKline Beecham, Hoffman-La Roche and BioResponse where she was responsible for developing outsourcing programs for raw materials and APIs, technology transfer, analytical and QA/QC programs and CMC and regulatory strategy for biopharmaceuticals in all development phases. |
| www.seraphimlifesciences.com (290 words) |
|